drugset / Trial / NCT05432284
Behavioral Pharmacology of THC and Beta-Myrcene
Phase 1
Not yet recruiting
32 enrolled
Johns Hopkins University
National Institute on Drug Abuse (NIDA) · collab
RandomizedCrossoverDouble-blindBasic science
Summary
This study will evaluate the pharmacokinetics and pharmacodynamics of vaporized b-myrcene and THC administered via inhalation.
Timeline
- Start
- 2026-07
- Primary completion
- 2027-11
- Completion
- 2027-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Myrcene | Small molecule | 2 mg | Inhaled |
| Subject | Myrcene | Small molecule | 9 mg | Inhaled |
| Subject | THC | Unknown | 15 mg | Inhaled |
| Subject | THC | Unknown | 30 mg | Inhaled |